BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 36376617)

  • 21. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
    Li Y; Zeng X
    Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
    Zhang Y; Zhou J; Li H; Liu Y; Li J
    BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
    Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
    Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis-related long non-coding RNA signature.
    Huang Q; You Q; Zhu N; Wu Z; Xiang Z; Wu K; Ren J; Gui Y
    J Clin Lab Anal; 2022 Nov; 36(11):e24723. PubMed ID: 36189780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
    Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
    Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of cuproptosis-related signature with the prognosis of patients with head and neck squamous cell carcinoma.
    Li Y; Sun C; Gu F; Yue J; Huang X; Yuan B; Wang Y; Chen R
    J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38279934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and immuno-infiltration analysis of cuproptosis regulators in human spermatogenic dysfunction.
    Zhao M; Yu WX; Liu SJ; Deng YJ; Zhao ZW; Guo J; Gao QH
    Front Genet; 2023; 14():1115669. PubMed ID: 37065492
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas.
    Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y
    Front Genet; 2022; 13():992995. PubMed ID: 36579333
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verification of cuproptosis-related diagnostic model associated with immune infiltration in rheumatoid arthritis.
    Jiang M; Liu K; Lu S; Qiu Y; Zou X; Zhang K; Chen C; Jike Y; Xie M; Dai Y; Bo Z
    Front Endocrinol (Lausanne); 2023; 14():1204926. PubMed ID: 37547319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of cuproptosis-related genes for predicting the development of prostate cancer.
    Wang X; Chen X; Xu C; Zhou W; Wu D
    Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma.
    Sun Q; Qin X; Zhao J; Gao T; Xu Y; Chen G; Bai G; Guo Z; Liu J
    Apoptosis; 2023 Feb; 28(1-2):247-262. PubMed ID: 36344660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis Regulates Microenvironment and Affects Prognosis in Prostate Cancer.
    Li C; Xiao Y; Cao H; Chen Y; Li S; Yin F
    Biol Trace Elem Res; 2024 Jan; 202(1):99-110. PubMed ID: 37155084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease.
    Liu L; Liang L; Yang C; Chen Y
    Front Immunol; 2023; 14():1136991. PubMed ID: 37275904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Guo T; Zhang J; Yuan Z; Tang H; Wang T; Wang X; Chen S
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer.
    Chu B; Wang Y; Yang J; Dong B
    Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of cuproptosis-related genes in prognosis and immune infiltration in grade 4 diffuse gliomas.
    Liu H; Bao X; Zeng Z; Liu W; Li M
    Heliyon; 2024 Apr; 10(7):e29212. PubMed ID: 38633656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma.
    Wang L; Wang D; Yang L; Zeng X; Zhang Q; Liu G; Pan Y
    Front Immunol; 2022; 13():989286. PubMed ID: 36618352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.